Electronic Resource
Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia.
| العنوان: | Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia. |
|---|---|
| المؤلفون: | Sue C.M., Fung V.S.C., Hayes M., Iansek R., Kimber T., O'Sullivan J.D., Williams D.R., Evans A.H. |
| بيانات النشر: | Blackwell Publishing Australia 2017-10-17 |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | In Australia 1% of individuals aged over 50 years have Parkinson disease (PD). Guidance for commencing device-assisted therapies (DAT) for PD in Australia was developed based on a review of European recommendations and their relevance to the local clinical setting. An online survey and teleconference discussions were held by a group of eight local movement disorder experts to develop consensus. Referral to a movement disorder specialist and consideration of DAT is appropriate when motor fluctuations cause disability or reduced quality of life, response to treatment is inconsistent or motor fluctuations and dyskinesias require frequent treatment adjustment without apparent benefit and levodopa is required four or more times daily. Three types of DAT are available in Australia for patients with PD: continuous subcutaneous apomorphine; continuous levodopa-carbidopa intestinal gel infusion; and deep brain stimulation. All improve consistency of motor response. The most important aspects when considering which DAT to use are the preferences of the patient and their carers, patient comorbidities, age, cognitive function and neuropsychiatric status. Patients and their families need to be provided with treatment options that are suitable to them, with adequate explanations regarding the recommendations and comparison of potential device-related complications. DAT are best managed, where possible, in a specialist centre with experience in all three types of therapy. Proactive and early management of symptoms during disease progression is essential to maintain optimally motor responses and quality of life in patients with PD.Copyright © 2017 Royal Australasian College of Physicians |
| مصطلحات الفهرس: | mental health, motor performance, Parkinson disease/dt [Drug Therapy], Parkinson disease/th [Therapy], patient preference, patient referral, priority journal, dysphagia/co [Complication], residential care, review, abnormal posture/co [Complication], speech disorder/co [Complication], treatment contraindication, quality of life, gait disorder/co [Complication], human, infusion pump, cognition, cognitive defect/co [Complication], comorbidity, dementia/co [Complication], depression, disease duration, disease severity, drug efficacy, dyskinesia/dt [Drug Therapy], treatment response, amantadine/dt [Drug Therapy], apomorphine/dt [Drug Therapy], apomorphine/sc [Subcutaneous Drug Administration], carbidopa plus levodopa/dt [Drug Therapy], age distribution, Australia, brain depth stimulation, clinical effectiveness, Review |
| URL: | Internal Medicine Journal Click here for full text options LibKey Link |
| الاتاحة: | Open access content. Open access content Copyright 2018 Elsevier B.V., All rights reserved. |
| Other Numbers: | AUSHL oai:repository.monashhealth.org:1/38503 Internal Medicine Journal. 47 (10) (pp 1107-1113), 2017. Date of Publication: October 2017. 1444-0903 https://repository.monashhealth.org/monashhealthjspui/handle/1/38503 28195385 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28195385] 618682001 (Williams) Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia (Evans) Neurology Department, The Royal Melbourne Hospital, Melbourne, VIC, Australia (Fung) Movement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia (Hayes) Department of Neuroscience, Concord Hospital, Sydney, NSW, Australia (Iansek) CRC for Movement Disorders and Gait Kingston Centre Monash Health, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia (Kimber) Neurology Unit, Royal Adelaide Hospital, Department of Medicine, University of Adelaide, Adelaide, SA, Australia (O'Sullivan) School of Medicine, University of Queensland, Brisbane, QLD, Australia (Sue) Department of Neurology, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia Williams D.R.; david.williams@monash.edu 1305128577 |
| المصدر المساهم: | MONASH HEALTH LIBRS From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1305128577 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |